New treatment options for diarrhea syndrome in the clinic of internal diseases
Journal Title: Сучасна гастроентерологія - Year 2019, Vol 0, Issue 2
Abstract
Acute and chronic diarrhea are severe clinical syndromes that can be observed in various diseases of internal organs. The unidentified cause of diarrhea syndrome hampers administration of the etiotropic therapy. The effective and timely treatment promotes the improvement of quality of life and prevents complications’ development. Smectalia is a new form of diosmectite, an antidiarrheal drug used to treat infectious and inflammatory bowel diseases, as well as diarrheal syndrome of various etiologies. Owing to its spatial structure and high plastic viscosity, diosmectite possesses a high enveloping capacity along the gastrointestinal mucosa. By interacting with mucosal glycoproteins, it increases the mucus layer thickness, mucin viscosity and decrease its solubility, restores the mucosa cytoprotective properties, thus raising its resistance to the effects of damaging factors (bile acids, free radicals, bacterial toxins). Diosmectite binds some of the bacterial and viral toxins that is believed to be a promoter for its antidiarrhea effects. There were some evidence-based clinical reports about the diosmectite effects on from the diarrhea in patients with the inflammatory intestinal diseases. Thus, it reduced diarrhea induced by endogenous agents, especially inflammatory cytokines or other factors, including at the inflammatory intestinal diseases. The literature reports the effective use of the dioctahedral smectite for the treatment of diarrhea at the endocrine pathology, and diarrhea resulting from radiotherapy, chemotherapy and procalcitonin acquired immunodeficiency syndrome. The understanding of the antidiarrheal diosmectite effects can open new possibilities for the treatment of acute and chronic diarrhea in the internal medicine clinic.
Authors and Affiliations
G. D. Fadieienko, T. A. Solomentseva
Keywords
Related Articles
- EP ID EP575020
- DOI 10.30978/MG-2019-2-39
- Views 155
- Downloads 0
Helicobacter pylori infection among the adults of Vinnytsya region, patients with nonatrophic and atrophic chronic gastritis
Objective — to assess the degree of Helicobacter pylori infection among the adult patients with chronic gastritis (CG) and its relationship with atrophic changes in the gastric mucosa. Materials and methods. The examina...
The drug induced liver injury: tactics of diagnosis and treatment
The article presents data of the drug induced liver injury, that plays an important role in the general structure of liver pathology. The basic directions of therapeutic correction of the drug induced liver injury been p...
Non-cirrhotic portal hypertension: clinical case and literature review
Non-cirrhotic portal hypertension can be caused by many factors. The authors presented a clinical case of portal hypertension that was eventually determined to be caused by repeated microthrombotic events on the basis of...
Inflammatory bowel diseases; 14th Congress of the European Crohn’s and Colitis Organisation (ECCO)
-
The modern paradigm of the chronic gastritis, associated with bile reflux
The authors considered the modern concepts of the mechanisms of formation and progression of chronic gastritis associated with bile reflux. The main factors responsible for the onset of duodenogastric reflux have been el...